New Horizon Pharmatech Private Limited - Company Profile

It is a trading private limited company based in New Delhi, Delhi, India, established in 2002.
2002 New Delhi, Delhi, India Active
Last Updated:
About New Horizon Pharmatech Private Limited

New Horizon Pharmatech Private Limited, a active private limited company, was established on 06 August 2002 in New Delhi, Delhi, India. Engaging in other wholesale within the trade sector, it holds CIN: U22122DL2002PTC116463. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.15 M.

It upholds a compliant status. Its leadership includes Nirmala Kumari (Director), Neelam Kumari (Director). Past directors included Vinit Kumar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at K-28, T/F South Extension Part Ii, New Delhi, Delhi, 110049.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U22122DL2002PTC116463

  • Registration Number

    116463

  • Incorporation Date

    06 August 2002

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 23 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -61.67%
  • Profit Growth **** -293.42%
  • Ebitda **** -44.53%
  • Net Worth -34.52%
  • Total Assets **** 24.54%
Company report

New Horizon Pharmatech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into New Horizon Pharmatech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at New Horizon Pharmatech Private Limited?
Current Directors
Name Designation Appointment Date Status
Nirmala Kumari Director 06 Aug 2002 Current
Neelam Kumari Director 06 Aug 2002 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 21 Sep 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of New Horizon Pharmatech.

New Horizon Pharmatech Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 61.67% decrease. The company also saw a substantial fall in profitability, with a 293.42% decrease in profit. The company's net worth observed a substantial decline by a decrease of 34.52%.

New Horizon Pharmatech revenue growth over time
New Horizon Pharmatech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-61.67%
*******
*******
*******
*******
Revenue from Operations
*******
-61.67%
*******
*******
*******
*******
Total Assets
*******
24.54%
*******
*******
*******
*******
Profit or Loss
*******
-293.42%
*******
*******
*******
*******
Net Worth
*******
-34.52%
*******
*******
*******
*******
EBITDA
*******
-44.53%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of New Horizon Pharmatech?

In 2017, New Horizon Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at New Horizon Pharmatech?

Unlock and access historical data on people associated with New Horizon Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of New Horizon Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Horizon Pharmatech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on New Horizon Pharmatech
Recent Activity within the Organization
  • Annual General Meeting

    New Horizon Pharmatech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on New Horizon Pharmatech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    Progress on Nirmala Kumari was appointed as a Director was appointed as a Director on 06 Aug 2002 & has been associated with this company since 23 years 6 months . was documented.

  • Director Appointment

    The activity Neelam Kumari was appointed as a Director was appointed as a Director on 06 Aug 2002 & has been associated with this company since 23 years 6 months . was completed.

  • Company Incorporation

    Progress on New Horizon Pharmatech Private Limited was registered on 06 Aug 2002 with Roc Delhi & aged 23 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of New Horizon Pharmatech Private Limited?

The CIN of New Horizon Pharmatech Private Limited is U22122DL2002PTC116463.

Where is New Horizon Pharmatech Private Limited headquartered?

New Horizon Pharmatech Private Limited is headquartered at K-28, T/F South Extension Part Ii, New Delhi, Delhi, 110049.

When was New Horizon Pharmatech Private Limited incorporated?

New Horizon Pharmatech Private Limited was incorporated on 06 August 2002.

Who are the current directors of New Horizon Pharmatech Private Limited?

The current directors of New Horizon Pharmatech Private Limited are

What is the primary industry of New Horizon Pharmatech Private Limited?

The primary industry of New Horizon Pharmatech Private Limited is Trade.

Is New Horizon Pharmatech Private Limited a listed company?

New Horizon Pharmatech Private Limited is unlisted.

What is the capital structure of New Horizon Pharmatech Private Limited?

The authorized capital of New Horizon Pharmatech Private Limited is ₹1.00 M, and the paid-up capital is ₹0.15 M.

What is the compliance status of New Horizon Pharmatech Private Limited?

The compliance status of New Horizon Pharmatech Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available